|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,400.00 JPY | +2.51% |
|
+2.17% | +14.04% |
| 02-06 | Japan's Nikkei rallies on earnings in unsteady trade before Sunday election | RE |
| 02-06 | Japanese drugmakers slump after Trump unveils discount drug website | RE |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals | 787B | 1T | 1,260B | 1,111B | 1,171B | |||||
Total Assets | 1,235B | 1,539B | 1,870B | 1,933B | 2,208B | |||||
Interest Expense | -62M | -48M | -61M | -27M | 5M | |||||
Income Tax Expense | 83.46B | 116B | 157B | 118B | 156B | |||||
CAPEX | -61.39B | -72.87B | -71.24B | -71.95B | -50.42B | |||||
EBT | 298B | 419B | 531B | 444B | 543B | |||||
Gross Profit | 513B | 662B | 784B | 698B | 831B | |||||
D&A | 30.38B | 30.87B | 31.43B | 31.74B | 31.66B | |||||
Operating Income | 602B | 844B | 1,067B | 411B | 540B | |||||
Net Income | 215B | 303B | 374B | 325B | 387B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Overseas | - | - | - | - | 537B | |||||
Japan | 419B | 522B | 657B | 559B | 461B | |||||
Unallocated | - | - | - | - | 173B | |||||
Other Overseas | 20.4B | 27.14B | 120B | 40.25B | - | |||||
Switzerland | 348B | 450B | 483B | 512B | - |
- Stock Market
- Equities
- 4519 Stock
- Financials Chugai Pharmaceutical Co., Ltd.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition